• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挽救性脐带血移植采用短期减低强度预处理方案治疗移植物失败。

Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure.

机构信息

Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Japan.

Department of Hematology, Faculty of Medicine, University of Tsukuba, Japan.

出版信息

Intern Med. 2022 Jun 1;61(11):1673-1679. doi: 10.2169/internalmedicine.7836-21. Epub 2021 Nov 20.

DOI:10.2169/internalmedicine.7836-21
PMID:34803091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9259308/
Abstract

Objective Graft failure (GF) is a life-threatening complication of hematopoietic stem cell transplantation (HSCT). A standardized conditioning regimen and an appropriate graft source of salvage HSCT for GF have not yet been established. Some case series have shown good hematopoietic recoveries after salvage HSCT using a short-term reduced-intensity preparative regimen consisting of fludarabine (30-90 mg/m), cyclophosphamide (2 g/m), and total-body irradiation (2 Gy). However, the dose of fludarabine has varied in these reports based on the clinical condition of the patients, resulting in very limited experiences with each dose of fludarabine. Methods We retrospectively analyzed 10 patients who developed GF after allogeneic HSCT and underwent salvage cord blood transplantation (CBT) using the above-mentioned conditioning regimen with a fixed dose (90 mg/m) of fludarabine. Results Eight patients (80.0%) achieved neutrophil engraftment within 30 days from salvage HSCT with a median of 21 (range, 17-23) days. The 1-year overall survival (OS) rate after the salvage HSCT was 50.0%, and the median OS was 281 (range, 23-1,638) days. Cumulative incidences of non-relapse mortality and relapse at 1 year were 50.0% and 10.0%, respectively. Conclusion CBT using this short-term reduced-intensity conditioning regimen may be a promising salvage therapy for GF.

摘要

目的

移植物失败(GF)是造血干细胞移植(HSCT)的一种危及生命的并发症。目前尚未建立针对 GF 的标准预处理方案和合适的挽救性 HSCT 供体。一些病例系列研究表明,采用由氟达拉滨(30-90mg/m)、环磷酰胺(2g/m)和全身照射(2Gy)组成的短期、低强度预处理方案进行挽救性 HSCT 后,造血恢复良好。然而,这些报告中氟达拉滨的剂量因患者的临床状况而异,导致对每种剂量的氟达拉滨的经验非常有限。方法:我们回顾性分析了 10 例在异基因 HSCT 后发生 GF 并接受上述预处理方案(氟达拉滨剂量固定为 90mg/m)进行挽救性脐带血移植(CBT)的患者。结果:8 例患者(80.0%)在挽救性 HSCT 后 30 天内实现了中性粒细胞植入,中位数为 21 天(范围,17-23 天)。挽救性 HSCT 后 1 年的总生存率(OS)为 50.0%,中位 OS 为 281 天(范围,23-1638 天)。1 年时非复发死亡率和复发累积发生率分别为 50.0%和 10.0%。结论:采用这种短期、低强度预处理方案的 CBT 可能是 GF 的一种有前途的挽救性治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a6/9259308/a293829d77b4/1349-7235-61-1673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a6/9259308/a293829d77b4/1349-7235-61-1673-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6a6/9259308/a293829d77b4/1349-7235-61-1673-g001.jpg

相似文献

1
Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure.挽救性脐带血移植采用短期减低强度预处理方案治疗移植物失败。
Intern Med. 2022 Jun 1;61(11):1673-1679. doi: 10.2169/internalmedicine.7836-21. Epub 2021 Nov 20.
2
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.同种异体造血细胞移植后原发性移植物失败患者行 1 天非清髓性挽救方案的结果。
Bone Marrow Transplant. 2012 May;47(5):700-5. doi: 10.1038/bmt.2011.158. Epub 2011 Aug 1.
3
Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation.脐带血移植中移植物失败经短期减低强度预处理方案和第二次同种异体移植成功治疗。
Int J Hematol. 2010 Dec;92(5):744-50. doi: 10.1007/s12185-010-0714-6. Epub 2010 Nov 5.
4
Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison.与标准强度降低的预处理后移植相比,基于噻替哌的强化降低强度预处理成人双单位脐带血造血干细胞移植可降低复发率并改善生存:回顾性队列比较。
Biol Blood Marrow Transplant. 2018 Aug;24(8):1671-1677. doi: 10.1016/j.bbmt.2018.04.019. Epub 2018 Apr 21.
5
Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.在自体造血干细胞移植失败后,使用氟达拉滨和马法兰进行减低剂量预处理进行第二次造血干细胞移植的可行性。
Transplant Proc. 2010 Nov;42(9):3723-8. doi: 10.1016/j.transproceed.2010.09.005.
6
Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.两种标准的降低强度预处理方案和两种不同移植物来源在血液病成人患者异基因干细胞移植中的疗效比较:一项单中心分析。
Biol Blood Marrow Transplant. 2013 Jun;19(6):934-9. doi: 10.1016/j.bbmt.2013.03.009. Epub 2013 Mar 21.
7
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.基于氟达拉滨的预处理方案可确保二次造血干细胞同种异体移植(HSCT)在治疗初次移植失败时实现植入。
Biol Blood Marrow Transplant. 2007 Nov;13(11):1313-23. doi: 10.1016/j.bbmt.2007.07.006. Epub 2007 Sep 7.
8
Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen.采用氟达拉滨、美法仑和低剂量抗胸腺细胞球蛋白预处理方案进行挽救性脐血移植的可行性。
Int J Hematol. 2019 Apr;109(4):463-469. doi: 10.1007/s12185-019-02610-4. Epub 2019 Feb 8.
9
Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients.降低强度脐带血移植作为移植物失败挽救治疗的可行性:一项全国性成年患者调查结果。
Biol Blood Marrow Transplant. 2011 Jun;17(6):841-51. doi: 10.1016/j.bbmt.2010.09.005. Epub 2010 Sep 16.
10
Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome.对于 MECOM 相关综合征的婴儿,采用低强度预处理方案进行异基因造血干细胞移植是有效的。
Int J Hematol. 2023 Apr;117(4):598-606. doi: 10.1007/s12185-022-03505-7. Epub 2022 Dec 14.

引用本文的文献

1
Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?急性白血病患儿异基因造血干细胞移植后的移植物失败:自体重建还是二次移植?
Stem Cell Res Ther. 2024 Apr 22;15(1):111. doi: 10.1186/s13287-024-03726-z.

本文引用的文献

1
Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus.采用改良单日预处理方案及霉酚酸酯与他克莫司预防移植物抗宿主病治疗急性髓性白血病移植失败的成功二次脐带血移植
J Clin Exp Hematop. 2015;55(2):89-96. doi: 10.3960/jslrt.55.89.
2
[Primary graft failure in a patient with refractory acute myeloid leukemia successfully treated with modified 'one-day'-based preparative regimen followed by cord blood transplantation].[一名难治性急性髓系白血病患者采用改良的基于“一日”的预处理方案后行脐血移植成功治疗原发性移植物功能衰竭]
Rinsho Ketsueki. 2015 Jun;56(6):711-5. doi: 10.11406/rinketsu.56.711.
3
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:I. 2014年诊断与分期工作组报告
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.
4
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients.异基因干细胞移植后移植物失败的结局:89例患者的研究
Leuk Lymphoma. 2015 Mar;56(3):656-62. doi: 10.3109/10428194.2014.930849. Epub 2014 Aug 4.
5
Graft failure in the modern era of allogeneic hematopoietic SCT.异基因造血干细胞移植时代的移植物失败。
Bone Marrow Transplant. 2013 Apr;48(4):537-43. doi: 10.1038/bmt.2012.239. Epub 2012 Dec 10.
6
Investigation of the freely available easy-to-use software 'EZR' for medical statistics.医学统计学中免费易用软件 EZR 的调查研究。
Bone Marrow Transplant. 2013 Mar;48(3):452-8. doi: 10.1038/bmt.2012.244. Epub 2012 Dec 3.
7
Peripheral-blood stem cells versus bone marrow from unrelated donors.外周血造血干细胞与无关供者骨髓。
N Engl J Med. 2012 Oct 18;367(16):1487-96. doi: 10.1056/NEJMoa1203517.
8
Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation.外周血是脐血移植后移植物失败患者挽救性移植中更可取的干细胞来源:日本造血细胞移植学会登记数据的回顾性分析。
Biol Blood Marrow Transplant. 2012 Sep;18(9):1407-14. doi: 10.1016/j.bbmt.2012.02.014. Epub 2012 Mar 16.
9
Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.非血缘供者移植中,降低强度预处理方案对血液恶性肿瘤患者移植物失败、移植物抗宿主病和生存的影响因素分析。
Biol Blood Marrow Transplant. 2011 Dec;17(12):1869-73. doi: 10.1016/j.bbmt.2011.07.008. Epub 2011 Jul 20.
10
Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation.脐带血移植中移植物失败经短期减低强度预处理方案和第二次同种异体移植成功治疗。
Int J Hematol. 2010 Dec;92(5):744-50. doi: 10.1007/s12185-010-0714-6. Epub 2010 Nov 5.